Quince Therapeutics, Inc. (QNCX) SEC Filings — 2024
18 SEC filings for Quince Therapeutics, Inc. (QNCX) in 2024.
Filings
- Quince Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Quince Therapeutics Files 8-K: Other Events — 8-K · Nov 14, 2024
- Lamond Files SC 13D for Quince Therapeutics — SC 13D · Nov 13, 2024
- Quince Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Quince Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Quince Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Aug 6, 2024
- Quince Therapeutics Faces Delisting Concerns — 8-K · Jun 21, 2024
- Quince Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 6, 2024
- Quince Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Quince Therapeutics, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 24, 2024
- Quince Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- Quince Therapeutics Reports Officer & Director Changes, Compensation — 8-K · Feb 15, 2024
- Quince Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Sofinnova Capital VIII Discloses Stake in Quince Therapeutics — SC 13G · Feb 12, 2024
- BML Investment Partners Amends 13G/A on Quince Therapeutics (QNCX) — SC 13G/A · Feb 7, 2024
- Quince Therapeutics Files Routine 8-K on Jan 23 Event — 8-K · Jan 29, 2024
- Quince Therapeutics Amends 8-K, Confirms QNCX Common Stock Listing — 8-K/A · Jan 5, 2024
- Quince Therapeutics Files Administrative 8-K on Dec 29, 2023 Event — 8-K · Jan 3, 2024